Results 81 to 90 of about 8,104 (211)
, 2017 Dimitrios Toumpanakis,1,2 Konstantinos Loverdos,1,2 Vassiliki Tzouda,1,2 Vyronia Vassilakopoulou,1,2 Eleni Litsiou,1,2 Christina Magkou,3 Vassiliki Karavana,1,2 Michael Pieper,4 Theodoros Vassilakopoulos1,2 1First Critical Care Department, Pulmonary ...
Litsiou E +8 more
core
What drug: Olodaterol/tiotropium [PDF]
, 2016 Frank is a pleasant 83-year-old gentleman who is a regular patient in your pharmacy. Frank was diagnosed with chronic obstructive pulmonary disease (COPD) a number of years ago when his symptoms had started to affect his day-to-day activities. Frank quit
Lau, Esther
core
Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease. [PDF]
, 2011 Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. Developments in the understanding of COPD have led to standard guidelines for diagnosis, treatment, and spirometry assessments, which have in turn ...
James Donohue +5 more
core +1 more source
International Journal of COPD, 2017 Jutta Beier,1 Robert Mroz,2,3 Anne-Marie Kirsten,4 Ferran Chuecos,5 Esther Garcia Gil5 1insaf Respiratory Research Institute, Wiesbaden, Germany; 2Centrum Medycyny Oddechowej, 3Medical University of Białystok, Białystok, Poland; 4Pulmonary Research ...
Beier J +4 more
doaj
, 2010 Shalini Naik, Khalid M Kamal, Patricia A Keys, Thomas J MatteiDuquesne University School of Pharmacy, Pittsburgh, PA, USAObjective: To assess the cost-effectiveness of 3 treatments (tiotropium, salmeterol, and no treatment) in patients with moderate ...
Shalini Naik +3 more
core
Socioeconomic gradients in tiotropium use among adults with COPD
, 2008 Paul D Blanc1,2,3, Mark D Eisner1,2, Edward H Yelin4,5, Gillian Earnest1, John R Balmes1,2, Steven E Gregorich6, Patricia P Katz4,51Division of Occupational and Environmental Medicine, 2Division of Pulmonary and Critical Care Medicine, 4Division of ...
Edward H Yelin +5 more
core
Tuberculosis and Respiratory Diseases, 2019 Background Efficacy and safety of tiotropium bromide, a muscarinic receptor antagonist, in treatment of asthma have been reported. However, its effect on airway remodeling in chronic asthma of the elderly has not been clearly verified.
Ji Young Kang, M.D., Ph.D. +6 more
doaj
Safety, tolerability and risk benefit analysis of tiotropium in COPD
, 2008 Yuji Oba, Tareq Zaza, Danish M ThameemUniversity of Missouri, School of Medicine, Division of Pulmonary, Critical Care and Environmental Medicine, Columbia, MO, USAAbstract: COPD is a chronic disease and, like many other chronic diseases, there is no ...
Yuji Oba, Tareq Zaza, Danish M Thameem
core
, 2020 The 3-min constant speed shuttle test (CSST) was used to examine the effect of tiotropium/olodaterol compared with tiotropium at reducing activity-related breathlessness in patients with chronic obstructive pulmonary disease (COPD). This was a randomised,
Macesic, Hemani +7 more
core +1 more source
Alternative mechanisms for tiotropium [PDF]
, 2020 a b s t r a c t Tiotropium is commonly used in the treatment of chronic obstructive pulmonary disease. Although largely considered to be a long-acting bronchodilator, its demonstrated efficacy in reducing the frequency of exacerbations and preliminary ...
K Racké +12 more
core